Who
Bonnie H. Anderson
Director
Company insider
Files Form 4 as: Director, Bruker; Executive Chairwoman, Veracyte; Director, Castle Biosciences.
In numbers
- Trades disclosed
- 295
- Buys
- 4
- Sells
- 60
- Bought
- $54K
- Sold
- $27.6M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 19 Feb 2014
- Last trade
- 15 Feb 2026
- Last filed
- 18 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Feb 2026filed 18 Feb 2026 | BRKR BrukerLife-science tools | SEC FORM 4 Code A | —4,520 at $0.00 | filing |
| 15 Feb 2026filed 18 Feb 2026 | BRKR BrukerLife-science tools | SEC FORM 4 Code A | —4,520 at $0.00 | filing |
| 15 Feb 2025filed 19 Feb 2025 | BRKR BrukerLife-science tools | SEC FORM 4 Code A | —3,298 at $0.00 | filing |
| 5 Jan 2024filed 9 Jan 2024 | BRKR BrukerLife-science tools | SEC FORM 4 Code A | —2,377 at $0.00 | filing |
| 2 Jun 2023filed 6 Jun 2023 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $35K1,304 at $26.72 | filing |
| 14 Apr 2023filed 18 Apr 2023 | VCYT Veracyteoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —34,000 at $0.00 | filing |
| 14 Apr 2023filed 18 Apr 2023 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code M | $191K34,000 at $5.61 | filing |
| 14 Apr 2023filed 18 Apr 2023 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $749K34,000 at $22.04 | filing |
| 15 Mar 2023filed 16 Mar 2023 | VCYT Veracyteoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —34,000 at $0.00 | filing |
| 15 Mar 2023filed 16 Mar 2023 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code M | $191K34,000 at $5.61 | filing |
| 15 Mar 2023filed 16 Mar 2023 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $774K34,000 at $22.76 | filing |
| 2 Mar 2023filed 3 Mar 2023 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $217K8,994 at $24.10 | filing |
| 17 Jan 2023filed 18 Jan 2023 | VCYT Veracyteoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —34,000 at $0.00 | filing |
| 17 Jan 2023filed 18 Jan 2023 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code M | $191K34,000 at $5.61 | filing |
| 17 Jan 2023filed 18 Jan 2023 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $776K29,506 at $26.30 | filing |
| 17 Jan 2023filed 18 Jan 2023 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $120K4,494 at $26.64 | filing |
| 11 Jan 2023filed 12 Jan 2023 | VCYT Veracyteoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —63,247 at $0.00 | filing |
| 11 Jan 2023filed 12 Jan 2023 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code M | $907K63,247 at $14.34 | filing |
| 11 Jan 2023filed 12 Jan 2023 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $1.6M63,247 at $25.13 | filing |
| 5 Jan 2023filed 9 Jan 2023 | BRKR BrukerLife-science tools | SEC FORM 4 Code A | —1,970 at $0.00 | filing |
News
Head to Head Analysis: Castle Biosciences (NASDAQ:CSTL) vs. Alignment Healthcare (NASDAQ:ALHC)CSTL · themarketsdaily.com · 15 Oct 2026Castle Biosciences (NASDAQ:CSTL) Insider Tobin Juvenal Sells 3,288 Shares of StockCSTL · themarketsdaily.com · 14 Oct 2026
0 headlines in the last 90 days name Bonnie H. Anderson; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.